Pt(II)-based
derivatives bearing a cyanocobalamin (CNCbl) unit
were synthesized in aqueous solutions, and the reaction mixtures were
examined by reversed-phase liquid chromatography with electrospray
ionization and linear ion trap mass spectrometry (MS). Isotopic pattern
analysis, multistage mass-spectra (MS/MS and MS
3
) interpretation,
and differential isotopic labeling were used to establish the chemical
composition and to suggest the chemical structures of reaction products.
When cisplatin (
cis
-[PtCl
2
(NH
3
)
2
]) was used as a Pt(II) drug derivative, a coordination
bond between diamminemonochloroplatinum(II) and the cyano group of
CNCbl, in turn linked covalently to the vitamin Co(III) ion, occurred.
The resulting conjugate with a Co
III
–CN–Pt
II
bridge was MS detected as a doubly positive charged ion
with the prevailing isotopologue at
m
/
z
810.26 (empirical formula [C
63
H
95
ClCo
III
N
16
O
14
PPt]
2+
). Likewise,
a peak signal centered at
m
/
z
811.26
was observed when
15
N-labeled cisplatin
cis
-[PtCl
2
(
15
NH
3
)
2
] was
used as Pt(II) complex, thus confirming the presence of both the cisplatin
amino groups in the conjugate. A bifunctional conjugate was obtained
between CNCbl and the
cis
-diamminediaquaplatinum(II),
that is,
cis
-[Pt(NH
3
)
2
(H
2
O)
2
]
2+
; in this case, the planar coordination
complex of Pt(II) was also involved in a covalent bond with the oxygen
atom of one of the CNCbl amide moieties. The peak signal detected
at
m
/
z
792.26 (empirical formula
[C
63
H
94
Co
III
N
16
O
14
PPt]
2+
) changed to
m
/
z
793.26 when the labeled
cis
-[Pt(
15
NH
3
)
2
(H
2
O)
2
]
2+
complex
was adopted for conjugation. Comparison between MS/MS spectra allowed
an extended structural characterization of both conjugates, as such
or
15
N-labeled. Two-dimensional heteronuclear (
1
H–
15
N) single quantum correlation NMR spectroscopy,
applied to
15
...